TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

HMTM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

HMTM

ST13

US500000079345433

Class

5

Filing

79345433

Registration

7245025

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

04/23/2024

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

05/12/2022

Registration date

12/19/2023

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/19/2023

Last transaction

12/19/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

16

Owner location

SG

Examiner

AGREDA, SAMANTHA

Law office

N50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

TauRx Therapeutics Ltd.

Representatives

Thad Chaloemtiarana Pattishall, McAuliffe, Newbury, Hilliard

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical and medical preparations for the treatment of neurological diseases and disorders, mental disorders, neurodegenerative diseases and disorders, infectious diseases, viral and parasitic diseases, malaria, neoplasms and blood disorders; chemical preparations for medical and pharmaceutical purposes for the treatment of neurological diseases and disorders, mental disorders, neurodegenerative diseases and disorders, infectious diseases, viral and parasitic diseases, malaria, neoplasms and blood disorders

Publications

History of USPTO decisions and trademark events.

25 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/23/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

04/02/2024

FIMP

FINAL DISPOSITION PROCESSED

04/02/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

03/19/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/19/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

12/19/2023

GPNX

NOTIFICATION PROCESSED BY IB

10/04/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/03/2023

PUBO

PUBLISHED FOR OPPOSITION

10/03/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

09/13/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

09/13/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/13/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/31/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/30/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/29/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/29/2023

RFNT

REFUSAL PROCESSED BY IB

05/24/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

05/02/2023

RFRR

REFUSAL PROCESSED BY MPU

05/02/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/14/2023

CNRT

NON-FINAL ACTION WRITTEN

03/13/2023

DOCK

ASSIGNED TO EXAMINER

03/02/2023

MAFR

APPLICATION FILING RECEIPT MAILED

07/26/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/22/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/21/2022

Continuous trademark protection

Get notified about every new filing that threatens HMTM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.